CD109 induces EGFR-mediated STAT3 phosphorylation, which supports SCC cell migration, proliferation, and the cancer stem cell phenotype, highlighting its role in enhancing tumor aggressiveness and inflammation. This evidence concerns the gene EGFR and cancer.